lundbeck.net
域名年龄: 26年9天HTTP/1.1 301 永久重定向 访问时间:2014年08月30日 16:10:47 目标网址:http://www.lundbeck.com/global 文件大小:0 语言环境:Servlet/2.4 JSP/2.0 HTTP/1.1 200 OK 缓存控制:private, s-maxage=0 类型:text/html; charset=utf-8 服务器:Microsoft-IIS/7.5 X-AspNetMvc-Version: 4.0 ASP.NET版本:4.0.30319 语言环境:ASP.NET 访问时间:2014年08月30日 16:10:47 文件大小:19333 网站编码:utf-8
CloseChoose region and then countryAfricaAmericasAsiaEuropeOceaniaSouth AfricaArgentinaBolivarian Republic of VenezuelaBrazilCanadaChileColombiaMexicoPanamaPeruUnited StatesChinaIsraelJapanKoreaSingaporeTurkeyAustriaBelgiumBulgariaCyprusCzech RepublicDenmarkEstoniaFinlandFranceGermanyGreeceIrelandItalyLatviaNetherlandsNorwayPolandPortugalRussiaSerbiaSlovakiaSloveniaSpainSwedenSwitzerlandUnited KingdomAustraliaNew ZealandOther Lundbeck sites› Lundbeck Foundation › Lundbeck InstituteGlobal contactsWe operate in more than 57 countries around the world. If your country is not on the list, please refer to our global contacts.View contactsLUNDBECK WORLDWIDEGlobalAbout usBrain diseasesInvestorCareersCorporate Responsibility Media Become a clinical study investigator Interested in becoming part of top-tier neuroscience research? Read more 1 of 4 Progress in Mind Progress in Mind is Lundbeck’s dedication to addressing the global burden of brain disease. Discover where Lundbeck contributes 2 of 4 Health, Safety & Environment strategy Lundbeck has a Health Safety and Environment (HSE) strategy to ensure a prioritized, coordinated and long-term HSE effort. Learn more 3 of 4 Solving the puzzle of the brain In recent years, researchers have taken important steps towards understanding how brain diseases develop and why they evolve the way they do. This knowledge may lead to new and improved treatments – which gives renewed hope to patients and their families. Read about R&D at Lundbeck 4 of 4 Latest releases Aug 20, 2014 ı Corporate Releases H. Lundbeck A/S increases its share capital by 2,778 shares (0.0014 % of outstanding shares) as a result of employee warrant exercise Aug 7, 2014 ı Corporate Releases Continued solid growth of 36% in New Products - now contributing 27% of revenue Jul 14, 2014 ı Corporate Releases Otsuka and Lundbeck submit New Drug Application for brexpiprazole for the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression View all releases SHARE PRICE at 16:59 119.2 DKK -0.418% Q2/H1 2014 results Lundbeck's 2014 half-yearly and second quarter results are now released. Download the report. See webcast of the investor presentation. The Lundbeck Magazine The Lundbeck Magazine portrays true patient stories and reviews the stigma surrounding people living with brain disease. Read the latest edition. Join Lundbeck Current open positions Browse global vacancies 70 Page last modified 27 August 2014 H. Lundbeck A/S Ottiliavej 9 | 2500 | Valby | Denmark | Phone +45 3630 1311 | Fax +45 3630 1940 Sitemap | Contact us | Disclaimer and privacy statement We respect your privacy - Learn more about the usage of Cookies on our website You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.
© 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询
2024-05-09 17:12, Process in 0.0055 second.